docetaxelpembrolizumabtislelizumabsitravatinib
…patient in sitravatinib+tislelizumab arm; 13 (6.8%) patients in docetaxel arm) (figure 1). One patient randomised to sitravatinib+tisleli…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: itravatinib ×
itravatinib
This drug is selected. Its supporting articles are shown below.